Familial hemophagocytic lymphohistiocytosis hepatitis is mediated by IFN-γ in a predominantly hepatic-intrinsic manner.
Interferon gamma (IFN-γ) is the main cytokine driving organ dysfunction in Familial Hemophagocytic Lymphohistiocytosis (FHL). Blockade of IFN-γ pathway ameliorates FHL hepatitis, both in animal models and in humans with FHL. Hepatocytes are known to express IFN-γ receptor (IFN-γ-R). However, whether...
Main Authors: | Tamir Diamond, Thomas N Burn, Mailyn A Nishiguchi, Danielle Minichino, Julie Chase, Niansheng Chu, Portia A Kreiger, Edward M Behrens |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0269553 |
Similar Items
-
509 AMG487, A CXCR3 Antagonist, changes the Inflammatory Milieu in Familial Hemophagocytic Lymphohistiocytosis (FHL) Hepatitis
by: Tamir Diamond, et al.
Published: (2023-04-01) -
CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis
by: Tamir Diamond, et al.
Published: (2023-07-01) -
Hemophagocytic lymphohistiocytosis: pediatric hepatic perspective
by: Manal Hamdy El-Sayed, et al.
Published: (2024-10-01) -
Hepatic sinusoidal hemophagocytosis with and without hemophagocytic lymphohistiocytosis.
by: Jacqueline De Gottardi, et al.
Published: (2019-01-01) -
HEMOPHAGOCYTAL LYMPHOHISTIOCYTOSIS
by: M.A. Maschan, et al.
Published: (2009-05-01)